BIOCEPT, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
BIOCEPT, INC. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$10.78 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2023-08-14
- BIOCEPT, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-06-30 was -$3.63M.
- BIOCEPT, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-03-31 was -$7.14M.
- BIOCEPT, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-12-31 was -$9.71M.
- BIOCEPT, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-09-30 was -$10.12M.
- BIOCEPT, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$32.09M.
- BIOCEPT, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$2.82M.
- BIOCEPT, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$17.81M.
- BIOCEPT, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2019 was -$25.14M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | -$3.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$10.78M 10-Q · filed 2023-08-14 | -$20.48M derived: sum of 3 quarters · filed 2023-08-14 | -$30.61M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2023-03-31 | -$7.14M 10-Q · filed 2023-05-10 | -$16.85M derived: sum of 2 quarters · filed 2023-05-10 | -$26.98M derived: sum of 3 quarters · filed 2023-05-10 | -$37.02M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-12-31 | -$9.71M derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-04-17 | -$19.83M derived: sum of 2 quarters · filed 2023-04-17 | -$29.88M derived: sum of 3 quarters · filed 2023-08-14 | -$32.09M 10-K · filed 2023-04-17 | ||||
| 2022-09-30 | -$10.12M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2023-04-17 | -$20.17M derived: sum of 2 quarters · filed 2023-08-14 | -$22.38M 10-Q/A · filed 2023-04-17 | -$13.56M 10-Q · filed 2022-11-21 | -$25.35M derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-06-30 | -$10.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$12.26M 10-Q · filed 2023-08-14 | -$8.02M 10-Q · filed 2022-11-10 | -$15.23M derived: sum of 3 quarters · filed 2023-08-14 | -$15.85M derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | -$2.21M 10-Q · filed 2023-05-10 | -$2.77M 10-Q · filed 2022-05-23 | -$5.18M derived: sum of 2 quarters · filed 2023-05-10 | -$5.81M derived: sum of 3 quarters · filed 2023-05-10 | -$7.63M derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | -$2.97M derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-04-17 | -$3.60M derived: sum of 2 quarters · filed 2023-04-17 | -$5.42M derived: sum of 3 quarters · filed 2023-04-17 | -$2.82M 10-K · filed 2023-04-17 | ||||
| 2021-09-30 | -$625.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2023-04-17 | -$2.45M derived: sum of 2 quarters · filed 2023-04-17 | $147.00K 10-Q/A · filed 2023-04-17 | $1.20M 10-Q · filed 2021-11-15 | $2.05M derived: sum of 4 quarters · filed 2023-04-17 | |||
| 2021-06-30 | -$1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-10 | $772.00K 10-Q · filed 2022-11-10 | $771.81K 10-Q · filed 2021-08-16 | $2.67M derived: sum of 3 quarters · filed 2022-11-10 | -$2.20M derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-03-31 | $2.60M 10-Q · filed 2022-05-23 | $2.60M 10-Q · filed 2021-05-12 | $4.50M derived: sum of 2 quarters · filed 2022-05-23 | -$377.36K derived: sum of 3 quarters · filed 2022-05-23 | -$6.87M derived: sum of 4 quarters · filed 2022-05-23 | |||
| 2020-12-31 | $1.90M derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-04-05 | -$2.98M derived: sum of 2 quarters · filed 2022-04-05 | -$9.47M derived: sum of 3 quarters · filed 2022-04-05 | -$17.81M 10-K · filed 2022-04-05 | -$17.81M 10-K · filed 2021-03-31 | |||
| 2020-09-30 | -$4.88M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-02-15 | -$11.37M derived: sum of 2 quarters · filed 2022-02-15 | -$19.71M 10-Q/A · filed 2022-02-15 | -$25.42M derived: sum of 4 quarters · filed 2022-02-15 | ||||
| 2020-06-30 | -$6.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$14.83M 10-Q · filed 2021-08-16 | -$20.54M derived: sum of 3 quarters · filed 2021-08-16 | -$26.24M derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | -$8.34M 10-Q · filed 2021-05-12 | -$14.05M derived: sum of 2 quarters · filed 2021-05-12 | -$19.75M derived: sum of 3 quarters · filed 2021-05-12 | |||||
| 2019-12-31 | -$5.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$11.41M derived: sum of 2 quarters · filed 2021-03-31 | -$25.14M 10-K · filed 2021-03-31 | |||||
| 2019-09-30 | -$5.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$19.42M 10-Q · filed 2020-11-16 | ||||||
| 2019-06-30 | -$13.73M 10-Q · filed 2020-08-13 |